To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy Adults

AZD9056 Relative Bioavailability Study

NCT00908934 ·Status: COMPLETED ·Phase: PHASE1

To Compare Safety and Pharmacokinetic Properties of CJ-30039 and Lipidil Supra

NCT01501435 ·Status: COMPLETED ·Phase: PHASE1

A Study of LY3045697 After Multiple Oral Dosing in Healthy Participants

NCT01821703 ·Status: COMPLETED ·Phase: PHASE1

To Evaluate the Pharmacokinetic Interactions and Safety in Healthy Volunteers

NCT05351840 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234

NCT07220954 ·Status: RECRUITING ·Phase: PHASE1

To Evaluate the Pharmacokinetic Characteristics and Safety in Healthy Volunteers

NCT06361277 ·Status: COMPLETED ·Phase: PHASE1

Phase I, Open Label,Crossover Food-Effect and Absolute Bioavailability Study of WCK2349 and WCK771 in Healthy Adult Human Volunteers

NCT01875939 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Absolute Bioavailability Study For Oral Crizotinib In Healthy Volunteers

NCT01168934 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety and PK of UI018

NCT05085184 ·Status: UNKNOWN ·Phase: PHASE1

Study to Compare Safety and Pharmacokinetics of "CG1801" and "CGL1802" in Healthy Volunteers

NCT03774355 ·Status: COMPLETED ·Phase: PHASE1

Relative Bioavailability Study to Assess Two Solid Formulations Compared to an Oral Solution of AZD3293 in Healthy Male and Non-Fertile Female Subjects

NCT02039180 ·Status: COMPLETED ·Phase: PHASE1

To Evaluate the Safety and Pharmacokinetic Interactions in Healthy Volunteers

NCT06378684 ·Status: COMPLETED ·Phase: PHASE1

Effect of Cytochrome P 450 3A4 Inhibition by Itraconazole on the Single Oral Dose Pharmacokinetics of Cilobradine

NCT02264041 ·Status: COMPLETED ·Phase: PHASE1

A Fixed-Sequence, Two-Period, Open-Label Drug-Drug Interaction Study to Assess the Effect of an Inhibitor of Cytochrome P450 Isoenzyme 3A4 and Permeability Glycoprotein 1 on the Pharmacokinetics of TD-1211

NCT01568411 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Bioavailability, Safety and Tolerability of a Solid Dosage Formulation Relative to a Suspension of JNJ-54175446 in Healthy Male and Female Participants

NCT02930694 ·Status: COMPLETED ·Phase: PHASE1

To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JC-001 and JLP-1901

NCT06171880 ·Status: COMPLETED ·Phase: PHASE1

Relative Bioavailability Of A Crizotinib Oral Liquid Formulation To Crizotinib Formulated Capsule

NCT01297595 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Pharmacokinetics (PK) of Etrumadenant Tablet and Capsule Formulations in Healthy Adult Participants

NCT05277012 ·Status: COMPLETED ·Phase: PHASE1

A Study to Compare and Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of UI059 and UIC202201

NCT06393881 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Safety, Tolerability, Pharmacokinetics of Single Rising Oral Doses of BI 1181181 in Healthy Male Volunteers, Including Investigation of the Effect of Food on the Bioavailability of BI 1181181

NCT02044406 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of KBP-5074 in Patients With Moderate Hepatic Impairment

NCT04534699 ·Status: COMPLETED ·Phase: PHASE1

A Relative Bioavailability Study of FOR-6219 in Capsule and Tablet Formulations

NCT04686669 ·Status: COMPLETED ·Phase: PHASE1

Oral Bioavailability of Two Solid Formulations of GLPG0259.

NCT01322451 ·Status: COMPLETED ·Phase: PHASE1

Food Effect, Oral & Intravenous Pharmacokinetics and Absolute Bioavailability of BAY1834845 Including Drug-drug Interaction With Methotrexate

NCT03244462 ·Status: COMPLETED ·Phase: PHASE1

A Bioequivalence Study to Compare Two Formulations of SHR-1314 After Subcutaneous Injection in Healthy Subjects

NCT04527484 ·Status: UNKNOWN ·Phase: PHASE1